Evidence map›Paper›PMID 41632113›Full record

ArticleUrolithiasis2026

Endoscopically visible Randall's plaques are an independent predictor of future stone events.

Natalie Meyer, Jean Lee, Victoria Liu, Lejla Pepic, Robert Pearce, Kevin Li, Kevin Shee, Jorge Mena, Justin Ahn, David Bayne and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Natalie MeyerDepartment of Surgery (Urology), University of Colorado Anschutz Medical Campus, 12631 E 17th Ave, Mail Stop C312, 80045, Aurora, CO, USA.
Jean LeeDepartment of Surgery (Urology), University of Colorado Anschutz Medical Campus, 12631 E 17th Ave, Mail Stop C312, 80045, Aurora, CO, USA.
Victoria LiuSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.
Lejla PepicSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.
Robert PearceSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.
Kevin LiDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Kevin SheeDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Jorge MenaDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Justin AhnDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
David BayneDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Marshall StollerDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Tom ChiDepartment of Urology, University of California San Francisco, San Francisco, CA, USA.
Wilson Sui *Department of Urology, University of California San Francisco, San Francisco, CA, USA. wilsonsi@med.umich.edu.
Heiko Yang *Department of Surgery (Urology), University of Colorado Anschutz Medical Campus, 12631 E 17th Ave, Mail Stop C312, 80045, Aurora, CO, USA. heiko.yang@cuanschutz.edu.

Funding

NRSA Training CoreTL1DK139565 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PHILIP A BEACHY, Chi-yuan Hsu · 2023 to 2026
$5.1M
Professional Development CoreU2CDK133488 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Marsha J Treadwell · 2023 to 2026
$4.1M
NIDDK NIH HHS TL1DK139565NIDDK NIH HHS U2CDK133488
6 · The paper itself

Abstract

Randall’s plaques have been long thought to be precursors for kidney stone formation, but how their presence impacts future stone recurrence is not known. The aim of this study was to determine whether patients with endoscopically visible plaques were more likely to have subsequent stone events compared to those without. The presence of Randall’s plaque in adult patients was prospectively assessed during endoscopic cases as part of the Registry for Stones of the Kidney and Ureter (ReSKU). In each case, the visible Randall’s plaque burden was scored by the attending surgeon as “none,” “minimal,” or “many.” Data regarding stone composition, 24-hour urine tests, and subsequent stone events on follow up were collected. Stone events were defined as patient-reported stone passage or any primary operation for kidney stones; second-look or staged operations were not counted as separate stone events. We identified 673 subjects with a Randall’s plaque assessment, of which 78 had “none,” 306 had “minimal,” and 289 had “many.” Despite having no significant differences in initial stone burden, subjects with visible Randall’s plaque (“minimal” or “many”) had a higher relative risk of stone recurrences after surgery compared to those without (RRR 1.711 (1.121–2.611), p = 0.01). Interestingly, no significant differences in 24-hour urine analytes were observed. Subjects with visible plaque were more likely to have calcium-based stones (84% vs. 58%, p < 0.001). The presence of endoscopically visible Randall’s plaque is associated with an increased risk of stone recurrence independent of urine composition.

Indexed as

Kidney CalculiUreteral CalculiAdultAgedCalcium OxalateFemaleHumansMaleMiddle AgedProspective StudiesRecurrenceRisk FactorsCalcium OxalateCalcium OxalateNephrolithiasisRandall's plaqueRecurrenceSupersaturation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.